Adaptive Biotechnologies Corp (ADPT) Insider Trading Disclosures
Adaptive Biotechnologies Corp (ADPT) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ADPT
CIK: 1478320
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: WA
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2018 12:00:00 AM
Lead Engagement PartnerOren Lang-Furr
Audit LocationSeattle, Washington, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-16 | 2026-10-14 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001780664-26-000041 | View SEC Doc Filr Page |
| 4 | 2026-10-13 | 2026-10-09 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001780664-26-000039 | View SEC Doc Filr Page |
| 4 | 2026-10-08 | 2026-10-06 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001780664-26-000037 | View SEC Doc Filr Page |
| 4 | 2026-10-08 | 2026-10-06 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001820885-26-000025 | View SEC Doc Filr Page |
| 144 | 2026-10-06 | — | 144 Filing | 0001950047-26-010075 | View SEC Doc Filr Page |
| 4 | 2026-10-05 | 2026-10-01 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001780664-26-000035 | View SEC Doc Filr Page |
| 4 | 2026-10-05 | 2026-10-01 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001780660-26-000024 | View SEC Doc Filr Page |
| 144 | 2026-10-01 | — | 144 Filing | 0001950047-26-009975 | View SEC Doc Filr Page |
| 4 | 2026-09-18 | 2026-09-16 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001780660-26-000022 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-15 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001820885-26-000023 | View SEC Doc Filr Page |
| 144 | 2026-09-16 | — | 144 Filing | 0001950047-26-009582 | View SEC Doc Filr Page |
| 144 | 2026-09-15 | — | 144 Filing | 0001950047-26-009505 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-08-31 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001852578-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-08-28 | 2026-08-26 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001852578-26-000005 | View SEC Doc Filr Page |
| 144 | 2026-08-26 | — | 144 Filing | 0001950047-26-008709 | View SEC Doc Filr Page |
| 144 | 2026-08-20 | — | 144 Filing | 0001958244-26-000543 | View SEC Doc Filr Page |
| 4 | 2026-08-20 | 2026-08-18 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001274139-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-08-17 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001780649-26-000014 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-08-17 | PRIMARY DOCUMENT | 0001237566-26-000003 | View SEC Doc Filr Page |
| 144 | 2026-08-19 | — | 144 Filing | 0001958244-26-000536 | View SEC Doc Filr Page |
| 144 | 2026-08-18 | — | 144 Filing | 0001950047-26-008364 | View SEC Doc Filr Page |
| 144 | 2026-08-18 | — | 144 Filing | 0001958244-26-000527 | View SEC Doc Filr Page |
| 144 | 2026-08-18 | — | 144 Filing | 0001958244-26-000526 | View SEC Doc Filr Page |
| 144 | 2026-08-17 | — | 144 Filing | 0001958244-26-000523 | View SEC Doc Filr Page |
| 144 | 2026-08-17 | — | 144 Filing | 0001958244-26-000521 | View SEC Doc Filr Page |